Biovitrum AB

Biovitrum plans merger with Swedish Orphan.
Nordic Business Report; 11/5/2009; 725 words; ...Orphan International AB creating a niche speciality...focusing on rare diseases. Biovitrum will pay SEK3.5bn...5bn. Shareholders in Biovitrum, including Investor AB (STO: INVE A), representing...capital and votes in Biovitrum in aggregate, have...

Biogen Idec and Biovitrum Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Trial.
Blood Weekly; 11/5/2009; 1184 words; Biogen Idec (NASDAQ: BIIB) and Biovitrum AB (STO: BVT) announced that they plan to advance the...Biotechnology Business, Biotechnology Company, Biovitrum AB, Clinical Trial Research, Coagulant, Drugs, Factor...

Other News To Note.
BIOWORLD Today; 11/4/2009; 3595 words; ...Mystic inhalation technology and another in-house formulation technology. (See BioWorld Today, Feb. 20, 2003.) o Biovitrum AB, of Stockholm, Sweden, and GlaxoSmithKline plc, of London, agreed to halt a Phase IIb study of BVT.933, a 5...

Arena's Obesity Drug Positive In First-Look Phase II Results.
BIOWORLD Today; 11/3/2009; 1242 words; ...2002, Stockholm, Sweden-based Biovitrum AB inked a potential $150 million...2002.) When last heard from, Biovitrum and GSK had decided to stop a Phase...annual meeting in New Orleans. "Biovitrum is no longer working on this...

Amgen Submits Fast-Track Palifermin BLA In Mucositis.
BIOWORLD Today; 11/3/2009; 1011 words; ...Hematology meeting. (See BioWorld Today, June 2, 2003, and Dec. 10, 2003.) As part of a $86.5 million deal, Biovitrum AB, of Stockholm, Sweden, has Nordic co-promotion rights to palifermin in oral chemotherapy-related inflammations...